What is the share price of Unichem Laboratories Ltd (UNICHEMLAB) today?
The share price of UNICHEMLAB as on 5th February 2026 is ₹429.75. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Unichem Laboratories Ltd (UNICHEMLAB) share?
The past returns of Unichem Laboratories Ltd (UNICHEMLAB) share are- Past 1 week: 12.50%
- Past 1 month: -1.24%
- Past 3 months: -8.09%
- Past 6 months: -20.35%
- Past 1 year: -40.59%
- Past 3 years: 36.97%
- Past 5 years: 34.87%
What are the peers or stocks similar to Unichem Laboratories Ltd (UNICHEMLAB)?
The peers or stocks similar to Unichem Laboratories Ltd (UNICHEMLAB) include:What is the market cap of Unichem Laboratories Ltd (UNICHEMLAB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Unichem Laboratories Ltd (UNICHEMLAB) is ₹3025.69 Cr as of 5th February 2026.What is the 52 week high and low of Unichem Laboratories Ltd (UNICHEMLAB) share?
The 52-week high of Unichem Laboratories Ltd (UNICHEMLAB) is ₹760 and the 52-week low is ₹361.05.What is the PE and PB ratio of Unichem Laboratories Ltd (UNICHEMLAB) stock?
The P/E (price-to-earnings) ratio of Unichem Laboratories Ltd (UNICHEMLAB) is 22.00. The P/B (price-to-book) ratio is 1.23.Which sector does Unichem Laboratories Ltd (UNICHEMLAB) belong to?
Unichem Laboratories Ltd (UNICHEMLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Unichem Laboratories Ltd (UNICHEMLAB) shares?
You can directly buy Unichem Laboratories Ltd (UNICHEMLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Unichem Laboratories Ltd
UNICHEMLAB Share Price
429.752.95% (+12.30)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
UNICHEMLAB Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
AvgFinancials growth has been moderate for a few years
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
UNICHEMLAB Performance & Key Metrics
UNICHEMLAB Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 10.26 | 1.23 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.40 | 5.62 | 0.61% |
UNICHEMLAB Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
UNICHEMLAB Company Profile
Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs or bulk actives).
SUNPHARMA
PE Ratio
37.38
37.38
1Y Return
2.86%
2.86%
Buy Reco %
94.44
94.44
TORNTPHARM
PE Ratio
70.41
70.41
1Y Return
27.67%
27.67%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
20.43
20.43
1Y Return
7.20%
7.20%
Buy Reco %
58.06
58.06
DRREDDY
PE Ratio
18.33
18.33
1Y Return
1.41%
1.41%
Buy Reco %
51.61
51.61
LUPIN
PE Ratio
30.89
30.89
1Y Return
1.53%
1.53%
Buy Reco %
72.22
72.22
UNICHEMLAB Forecast
UNICHEMLAB Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
UNICHEMLAB
UNICHEMLAB
Income
Balance Sheet
Cash Flow
Annual Normal View
UNICHEMLAB Income Statement
UNICHEMLAB Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 882.81 | 3,553.47 | 1,280.29 | 1,195.84 | 1,285.33 | 1,317.34 | 1,381.54 | 1,884.71 | 2,146.29 | 2,538.27 | ||||||||||
Raw Materials | 262.42 | 387.73 | 477.13 | 422.92 | 467.52 | 457.36 | 533.73 | 843.66 | 1,064.02 | 2,055.02 | ||||||||||
| Power & Fuel Cost | 41.62 | 49.23 | 76.39 | 73.02 | 68.89 | 78.05 | 102.84 | 107.14 | 108.16 | |||||||||||
| Employee Cost | 169.04 | 200.64 | 238.52 | 273.28 | 306.97 | 330.49 | 356.41 | 403.20 | 402.21 | |||||||||||
| Selling & Administrative Expenses | 233.92 | 291.18 | 420.94 | 345.54 | 316.35 | 287.13 | 299.84 | 347.57 | 367.18 | |||||||||||
| Operating & Other expenses | 32.10 | 17.93 | 50.56 | 39.77 | -15.36 | 45.07 | 134.33 | 122.28 | -95.46 | |||||||||||
EBITDA | 143.71 | 2,606.76 | 16.75 | 41.31 | 140.96 | 119.24 | -45.61 | 60.86 | 300.18 | 483.25 | ||||||||||
| Depreciation/Amortization | 43.52 | 50.51 | 67.37 | 81.67 | 84.36 | 91.17 | 113.44 | 123.16 | 124.56 | 124.20 | ||||||||||
| PBIT | 100.19 | 2,556.25 | -50.62 | -40.36 | 56.60 | 28.07 | -159.05 | -62.30 | 175.62 | 359.05 | ||||||||||
| Interest & Other Items | 3.36 | 8.01 | 7.52 | 7.85 | 5.12 | 6.11 | 17.31 | 22.66 | 21.03 | 27.66 | ||||||||||
| PBT | 96.83 | 2,548.24 | -58.14 | -48.21 | 51.48 | 21.96 | -176.36 | -84.96 | 154.59 | 331.39 | ||||||||||
| Taxes & Other Items | -11.85 | 3.34 | -34.35 | 11.97 | 17.15 | -11.09 | 25.86 | 8.80 | 17.07 | 36.49 | ||||||||||
| Net Income | 108.68 | 2,544.90 | -23.79 | -60.18 | 34.33 | 33.05 | -202.22 | -93.76 | 137.52 | 294.90 | ||||||||||
| EPS | 11.96 | 315.72 | -3.38 | -8.55 | 4.88 | 4.69 | -28.72 | -13.32 | 19.53 | 41.89 | ||||||||||
| DPS | 3.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.25 | 0.02 | 0.00 | 0.00 | 0.82 | 0.85 | 0.00 | 0.00 | 0.00 | 0.00 |
UNICHEMLAB Company Updates
UNICHEMLAB Stock Peers
UNICHEMLAB Past Performance & Peer Comparison
UNICHEMLAB Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Unichem Laboratories Ltd | 22.00 | 1.23 | — |
| Sun Pharmaceutical Industries Ltd | 37.38 | 5.64 | 0.94% |
| Torrent Pharmaceuticals Ltd | 70.41 | 17.73 | 0.80% |
| Cipla Ltd | 20.43 | 3.44 | 1.20% |
UNICHEMLAB Stock Price Comparison
Compare UNICHEMLAB with any stock or ETFCompare UNICHEMLAB with any stock or ETF
UNICHEMLAB
UNICHEMLAB Holdings
UNICHEMLAB Shareholdings
UNICHEMLAB Promoter Holdings Trend
UNICHEMLAB Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
UNICHEMLAB Institutional Holdings Trend
UNICHEMLAB Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
UNICHEMLAB Shareholding Pattern
UNICHEMLAB Shareholding Pattern
UNICHEMLAB Shareholding History
UNICHEMLAB Shareholding History
Foreign Institutions
Mutual Funds Invested in UNICHEMLAB
Mutual Funds Invested in UNICHEMLAB
No mutual funds holding trends are available
Top 5 Mutual Funds holding Unichem Laboratories Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 8.2063% | Percentage of the fund’s portfolio invested in the stock 0.64% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 58/87 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2810% | Percentage of the fund’s portfolio invested in the stock 1.21% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/34 (+2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2221% | Percentage of the fund’s portfolio invested in the stock 0.38% | Change in the portfolio weight of the stock over the last 3 months -0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 26/49 (-4) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing UNICHEMLAB stock
smallcases containing UNICHEMLAB stock
Looks like this stock is not in any smallcase yet.
UNICHEMLAB Events
UNICHEMLAB Events
UNICHEMLAB Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
UNICHEMLAB Dividend Trend
No dividend trend available
UNICHEMLAB Upcoming Dividends
UNICHEMLAB Upcoming Dividends
No upcoming dividends are available
UNICHEMLAB Past Dividends
UNICHEMLAB Past Dividends
Cash Dividend
Ex DateEx DateAug 1, 2022
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Aug 1, 2022
Cash Dividend
Ex DateEx DateJul 22, 2021
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Jul 22, 2021
Cash Dividend
Ex DateEx DateAug 20, 2020
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Aug 20, 2020
Cash Dividend
Ex DateEx DateJul 18, 2019
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Jul 18, 2019
Cash Dividend
Ex DateEx DateJul 19, 2018
Final
Final | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Jul 19, 2018
UNICHEMLAB Stock News & Opinions
UNICHEMLAB Stock News & Opinions
Articles & Videos
Earnings
Unichem Laboratories consolidated net profit rises 356.85% in the December 2025 quarter
Net profit of Unichem Laboratories rose 356.85% to Rs 264.29 crore in the quarter ended December 2025 as against Rs 57.85 crore during the previous quarter ended December 2024. Sales declined 2.24% to Rs 521.17 crore in the quarter ended December 2025 as against Rs 533.09 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales521.17533.09 -2 OPM %8.5916.04 - PBDT49.1692.39 -47 PBT17.9161.85 -71 NP264.2957.85 357 Powered by Capital Market - Live
11 hours agoCapital Market - Live
Spotlight
Unichem Laboratories' Kolhapur API Facility clears USFDA inspection
The inspection concluded with five observations, all pertaining to procedural changes, with none related to data integrity. The company said it will submit the required response to the USFDA within the stipulated 15-day period. Unichem Laboratories is engaged in manufacturing of pharmaceutical products. The company's consolidated jumped 83.9% to Rs 45.30 crore on 14.1% increase in net sales to Rs 578.96 crore in Q2 FY26 over Q2 FY25. Shares of Unichem Laboratories rose 0.16% to Rs 374.65 on the BSE. Powered by Capital Market - Live
3 days agoCapital Market - Live
Corporate
Unichem Laboratories announces board meeting date
Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Unichem Laboratories reports consolidated net loss of Rs 11.89 crore in the September 2025 quarter
Net loss of Unichem Laboratories reported to Rs 11.89 crore in the quarter ended September 2025 as against net profit of Rs 24.63 crore during the previous quarter ended September 2024. Sales rose 14.11% to Rs 578.96 crore in the quarter ended September 2025 as against Rs 507.36 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales578.96507.36 14 OPM %11.4310.94 - PBDT78.9159.39 33 PBT47.4427.13 75 NP-11.8924.63 PL Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Unichem Laboratories reports standalone net loss of Rs 39.93 crore in the September 2025 quarter
Net loss of Unichem Laboratories reported to Rs 39.93 crore in the quarter ended September 2025 as against net profit of Rs 43.37 crore during the previous quarter ended September 2024. Sales declined 18.31% to Rs 356.90 crore in the quarter ended September 2025 as against Rs 436.88 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales356.90436.88 -18 OPM %2.1614.76 - PBDT25.4269.76 -64 PBT-4.6943.37 PL NP-39.9343.37 PL Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Unichem Laboratories to announce Quarterly Result
Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Unichem Lab's Roha API facility receives EIR report
Unichem Laboratories announced that USFDA has classified the inspection of the company's Roha API facility as Voluntary Action Initiated (VAI) and received the Establishment Inspection Report. Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Unichem Laboratories reports consolidated net loss of Rs 10.47 crore in the June 2025 quarter
Net loss of Unichem Laboratories reported to Rs 10.47 crore in the quarter ended June 2025 as against net profit of Rs 2.07 crore during the previous quarter ended June 2024. Sales rose 8.95% to Rs 526.60 crore in the quarter ended June 2025 as against Rs 483.34 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales526.60483.34 9 OPM %4.278.31 - PBDT22.7739.88 -43 PBT-9.027.81 PL NP-10.472.07 PL Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Unichem Laboratories to table results
Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 4 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Spotlight
Unichem Labs slides after receiving three USFDA observations at Roha facility
In a regulatory filing, the company stated that the USFDA conducted the inspection from 16 June to 20 June 2025. At the conclusion of the inspection, the USFDA issued three observations, which were primarily related to procedural changes, with none related to data integrity. The company stated that it will provide the necessary response to the USFDA within the stipulated 15-day period. The official announcement was made on Saturday, 21 June 2025. Unichem Laboratories is engaged in the manufacturing of pharmaceutical products. The company reported a consolidated net profit of Rs 52.97 crore in Q4 FY25, compared with a net loss of Rs 129.31 crore in Q4 FY24. Revenue from operations jumped 36% year-on-year to Rs 587.18 crore in Q4 FY25. Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 12.41%, vs industry avg of 10.04%
Over the last 5 years, market share increased from 0.48% to 0.51%